Ghent University, the University of Antwerp and BioTools Europe Ltd have partnered to create the European Centre for Chirality (EC2), which is dedicated to advancing understanding of the part chirality plays in biological processes.
24 September, 2010
Ten amateur cyclists from pharmaceutical manufacturer Quantum Pharmaceutical have completed a gruelling thousand mile charity bike ride to raise £5000 for Marie Curie Cancer Care.
16 September, 2010
Cancer Research UK and Cancer Research Technology have reached an agreement with AstraZeneca to take compound AZD-3965, a first-of-its-kind experimental drug that could treat a range of cancers, into clinical trial.
13 September, 2010
Charles River Laboratories, a global preclinical contract research organization, now offers BlueScreen HC Screening services for the early detection of genotoxicity.
09 September, 2010
MorphoSys AG has announced a new proprietary development program against novel infectious disease targets. As part of this initiative, MorphoSys has signed a license and collaboration agreement with UK-based Absynth Biologics.
03 September, 2010